Granahan Investment Management INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 317 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.

Granahan Investment Management ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$8,441
-0.8%
150,835
-8.2%
0.28%
-4.8%
Q2 2022$8,506
+26.4%
164,345
+77.5%
0.29%
+73.7%
Q1 2022$6,730
-50.8%
92,609
-20.0%
0.17%
-40.8%
Q4 2021$13,690
-45.4%
115,783
-38.1%
0.28%
-40.8%
Q3 2021$25,084
-31.4%
186,985
-17.2%
0.48%
-30.1%
Q2 2021$36,560
+117.6%
225,803
+7.8%
0.68%
+91.3%
Q1 2021$16,805
+152.9%
209,389
+71.4%
0.36%
+138.9%
Q4 2020$6,645
+351.4%
122,143
+65.0%
0.15%
+198.0%
Q3 2020$1,472
-8.2%
74,034
-3.0%
0.05%
-13.8%
Q2 2020$1,604
+120.9%
76,305
+28.6%
0.06%
+48.7%
Q1 2020$726
-17.7%
59,342
-1.3%
0.04%
-4.9%
Q4 2019$882
+10.7%
60,107
+0.7%
0.04%
-6.8%
Q3 2019$797
-11.7%
59,691
+8.2%
0.04%
-2.2%
Q2 2019$903
-6.8%
55,163
-2.8%
0.04%
-13.5%
Q1 2019$969
+16.7%
56,760
-6.7%
0.05%
-11.9%
Q4 2018$830
-64.8%
60,834
-26.1%
0.06%
-53.9%
Q3 2018$2,357
-28.6%
82,359
-31.7%
0.13%
-35.7%
Q2 2018$3,301
+41.7%
120,645
+9.2%
0.20%
+18.5%
Q1 2018$2,329
-7.2%
110,442
-15.4%
0.17%
-14.7%
Q4 2017$2,510
-64.7%
130,608
-54.4%
0.20%
-66.8%
Q3 2017$7,111
+66.2%
286,144
+7.0%
0.59%
+50.5%
Q2 2017$4,278267,3600.39%